Written Question·Department of Health and Social Care·UIN 38239

Relugolix/estradiol/norethisterone: Northern Ireland

Tabled: 13 March 2025

Answered: 19 March 2025

Question

Sorcha Eastwood

To ask the Secretary of State for Health and Social Care, whether the National Institute for Health and Care Excellence's recommendation of relugolix-estradiol-norethisterone for routine NHS use to treat endometriosis will extend to Northern Ireland.

Answer

Karin Smyth

The National Institute for Health and Care Excellence (NICE) makes recommendations on whether new medicines should be routinely funded by the National Health Service in England. NICE published final draft guidance on 13 March 2025 that recommends relugoli...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 38239) →